ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC45773-10mg |
|
— |
2-chloro-N6-Cyclopentyladenosine (hydrate)
|
0 | C15H20ClN5O4.0.5H2O | |
GC45773-5mg |
|
— |
2-chloro-N6-Cyclopentyladenosine (hydrate)
|
0 | C15H20ClN5O4.0.5H2O | |
GC45772-25mg |
|
1015-89-0 |
6(5H)-Phenanthridinone
|
0 | C13H9NO | |
GC45772-10mg |
|
1015-89-0 |
6(5H)-Phenanthridinone
|
0 | C13H9NO | |
GC45772-5mg |
|
1015-89-0 |
6(5H)-Phenanthridinone
|
0 | C13H9NO | |
GC45772-1mg |
|
1015-89-0 |
6(5H)-Phenanthridinone
|
0 | C13H9NO | |
GC45771-10mg |
|
2182653-84-3 |
LH1306
|
0 | C38H48N6O6 | |
GC45771-5mg |
|
2182653-84-3 |
LH1306
|
0 | C38H48N6O6 | |
GC45771-1mg |
|
2182653-84-3 |
LH1306
|
0 | C38H48N6O6 | |
GC45770-10mg |
|
2250261-59-5 |
Prostaglandin D Synthase (hematopoietic-type) Inhibitor F092
|
0 | C20H17N5O2 | |
GC45770-5mg |
|
2250261-59-5 |
Prostaglandin D Synthase (hematopoietic-type) Inhibitor F092
|
0 | C20H17N5O2 | |
GC45770-1mg |
|
2250261-59-5 |
Prostaglandin D Synthase (hematopoietic-type) Inhibitor F092
|
0 | C20H17N5O2 | |
GC45769-5mg |
|
1174683-49-8 |
Vandetanib-d6
|
0 | C22H18BrD6FN4O2 | |
GC45769-1mg |
|
1174683-49-8 |
Vandetanib-d6
|
0 | C22H18BrD6FN4O2 | |
GC45769-500μg |
|
1174683-49-8 |
Vandetanib-d6
|
0 | C22H18BrD6FN4O2 | |
GC45768-1mg |
|
— |
Pranlukast-d4
|
0 | C27H19D4N5O4 | |
GC45767-1mg |
|
1246819-84-0 |
Dovitinib-d8
|
0 | C21H13D8FN6O | |
GC45766-1mg |
|
— |
Amprenavir-d4
|
0 | C25H31D4N3O6S | |
GC45766-500μg |
|
— |
Amprenavir-d4
|
0 | C25H31D4N3O6S | |
GC45765-1mg |
|
1346601-82-8 |
Deferiprone-d3
|
0 | C7H6D3NO2 | |